XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net Loss $ (43,843) $ (4,445)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 34,783 12,246
Asset impairments 16,969  
Amortization of debt issuance cost 200  
Loss (gain) on investments, net 10,395 (3,320)
Stock-based compensation expense 15,912 5,457
Deferred income taxes (26,366) 437
Other, net 32 89
Inventory reserves (6,681) (4,789)
Changes in operating assets and liabilities:    
Accounts receivable, net (34,535) (26,346)
Other receivables (2,154) 11,152
Inventory (76,293) 2,120
Prepaid expenses, other current assets and other assets 610 (8,514)
Accounts payable 70,381 29,614
Accrued expenses and other liabilities (23,005) 10,392
Income taxes payable, net 20,862 4,798
Net cash (used in) provided by operating activities (42,733) 28,891
Cash flows from investing activities:    
Purchases of property, plant and equipment (10,141) (3,572)
Proceeds from sales and maturities of available-for-sale investments 30,474 28,305
Purchases of available-for-sale investments (22,215) (28,853)
Proceeds from beneficial interests in securitized accounts receivable 1,294  
Proceeds from disposals of property, plant and equipment 12  
Insurance proceeds received   500
Acquisition of business, net of cash acquired 43,957  
Net cash provided by (used in) investing activities 43,381 (3,620)
Cash flows from financing activities:    
Tax withholdings related to stock-based compensation settlements (515) (113)
Proceeds from stock option exercises 5,434 6,111
Dividend payments (15,859) (13,124)
Proceeds from draw on revolving credit agreements 133,141  
Repayment of revolving credit agreements (48,000)  
Payment of debt issuance cost 3,015  
Repayment of notes payable (10,057)  
Net cash provided by (used in) financing activities 61,129 (7,126)
Net increase in cash, cash equivalents and restricted cash 61,777 18,145
Effect of exchange rate changes (7,496) (2,719)
Cash, cash equivalents and restricted cash, beginning of period 56,818 60,179
Cash, cash equivalents and restricted cash, end of period 111,099 75,605
Supplemental disclosure of cash financing activities:    
Cash paid for interest 633  
Supplemental disclosure of non-cash investing activities:    
Right-of-use assets obtained in exchange for lease obligations 904 1,833
Purchases of property, plant and equipment included in accounts payable 1,037 $ 100
ADVA common shares exchanged in acquisition 565,491  
ADVA options issued in acquisition 12,769  
Noncontrolling interest related to ADVA $ 316,415